Study of Ther Effect of Vildagliptin Versus Dapagliflozin on Glucagon Response to Mixed Meal in Metformin-treated Subjects With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Vildagliptin (Primary) ; Dapagliflozin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Jul 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 25 Feb 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.